Interventional procedure overview of botulinum toxin type A injection into the urethral sphincter for idiopathic chronic non-obstructive urinary retention
Closed for comments This consultation ended on at Request commenting lead permission
Additional information considered by IPAC
Professional experts' opinions
Expert advice was sought from consultants who have been nominated or ratified by their professional Society or Royal College. The advice received is their individual opinion and is not intended to represent the view of the society. The advice provided by professional experts, in the form of the completed questionnaires, is normally published in full on the NICE website during public consultation, except in circumstances but not limited to, where comments are considered voluminous, or publication would be unlawful or inappropriate. Three professional expert questionnaires for botulinum toxin type A injection into the urethral sphincter for idiopathic chronic non-obstructive urinary retention were submitted and can be found on the NICE website.
Patient commentators' opinions
NICE's Public Involvement Programme will send questionnaires to NHS trusts for distribution to patients who had the procedure (or their carers). When NICE has received the completed questionnaires, these will be discussed by the committee.
Company engagement
There is no specific device used for this procedure. Therefore, no structured information requests were sent to companies.
Issues for consideration by IPAC
Botulinum injections into the EUS for idiopathic chronic non-obstructive urinary retention is currently done on an off-label basis.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions